Clinical Trials Directory

Trials / Completed

CompletedNCT03765242

Evaluation of Safety and Effectiveness on Oral Anticoagulants

Retrospective Medical Chart Review Study for Atrial Fibrillation Patents Treated With Oral Anticoagulant

Status
Completed
Phase
Study type
Observational
Enrollment
12,354 (actual)
Sponsor
Bristol-Myers Squibb · Industry
Sex
All
Age
20 Years
Healthy volunteers
Not accepted

Summary

This study is to compare the risk of major bleeding among oral anticoagulant (OAC)-naïve non-valvular atrial fibrillation (NVAF) patients initiating treatment

Conditions

Interventions

TypeNameDescription
OTHERNon-InterventionalNon-Interventional

Timeline

Start date
2018-09-21
Primary completion
2020-12-25
Completion
2020-12-25
First posted
2018-12-05
Last updated
2022-05-13

Locations

1 site across 1 country: Japan

Source: ClinicalTrials.gov record NCT03765242. Inclusion in this directory is not an endorsement.

Evaluation of Safety and Effectiveness on Oral Anticoagulants (NCT03765242) · Clinical Trials Directory